VYNE THERAPEUTICS INC's ticker is VYNE and the CUSIP is 92941V209. A total of 46 filers reported holding VYNE THERAPEUTICS INC in Q1 2022. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2022 | $235,500 | -60.5% | 1,570,000 | -41.2% | 0.54% | -11.9% |
| Q3 2022 | $596,000 | -42.6% | 2,670,000 | 0.0% | 0.61% | -40.8% |
| Q2 2022 | $1,038,000 | -40.2% | 2,670,000 | 0.0% | 1.04% | +73.4% |
| Q1 2022 | $1,736,000 | -33.3% | 2,670,000 | +4.7% | 0.60% | -70.2% |
| Q4 2021 | $2,602,000 | +70.2% | 2,551,000 | +131.9% | 2.01% | +29.4% |
| Q3 2021 | $1,529,000 | -60.4% | 1,100,000 | 0.0% | 1.55% | -44.3% |
| Q2 2021 | $3,861,000 | -45.7% | 1,100,000 | +6.0% | 2.79% | -36.6% |
| Q1 2021 | $7,106,000 | – | 1,038,145 | – | 4.40% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| DSC Advisors, L.P. | 2,551,000 | $2,602,000 | 2.01% |
| Perceptive Advisors | 4,356,044 | $4,444,000 | 0.03% |
| GSA CAPITAL PARTNERS LLP | 217,747 | $222,000 | 0.03% |
| Virtu Financial LLC | 175,278 | $179,000 | 0.02% |
| XTX Topco Ltd | 17,053 | $17,000 | 0.01% |
| SkyOak Wealth, LLC | 27,200 | $28,000 | 0.01% |
| DELTEC ASSET MANAGEMENT LLC | 30,000 | $31,000 | 0.01% |
| Tekla Capital Management LLC | 135,395 | $138,000 | 0.00% |
| STALEY CAPITAL ADVISERS INC | 62,500 | $64,000 | 0.00% |
| TWO SIGMA SECURITIES, LLC | 47,475 | $48,000 | 0.00% |